BackLifeMD Overview
LifeMD Inc

LifeMD Target Price

Analysts' average 12-month price target for LifeMD is $7.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.13

Average Target Price

$7.00228.6% upside

5 analysts in the last 4 months

High: $9 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-18H.C. WainwrightYi Chen$9322.5% upsideOpen
2026-08-07KeyBancScott Schoenhaus$5134.7% upsideOpen
2026-08-06Lake Street$5134.7% upsideOpen
2026-08-06Mizuho Securities$7228.6% upsideOpen
2026-08-06BTIG$9322.5% upsideOpen
2026-05-27H.C. WainwrightYi Chen$10369.5% upsideOpen
2026-03-12Loop Capital MarketsIlya Zubkov$10369.5% upsideOpen
2025-11-24Loop Capital MarketsIlya Zubkov$8275.6% upsideOpen
2025-11-19Mizuho SecuritiesSteven Valiquette$6181.7% upsideOpen
2025-11-19KeyBancScott Schoenhaus$8275.6% upsideOpen
2025-11-18BTIG$10369.5% upsideOpen
2025-07-10Lake StreetBrooks O'Neil$18745.1% upsideOpen
2025-03-12H.C. WainwrightYi Chen$14557.3% upsideOpen
2025-01-08KeyBancScott Schoenhaus$7228.6% upsideOpen
2024-12-10Lake StreetBrooks O'Neil$12463.4% upsideOpen
2024-10-14BTIGKyle Bauser$12463.4% upsideOpen
2024-06-04KeyBancSteve Dechert$12463.4% upsideOpen
2024-04-23BTIGDavid Larsen$14557.3% upsideOpen

LifeMD (LFMD) FAQ

LifeMD (LFMD) currently reports a target price of $7. Use the charts on this page to explore LifeMD's target price history and peer comparisons.

Analysts' average 12-month price target for LifeMD is $7, about 228.6% upside from the current share price of $2.13. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $7, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LifeMD, and consider following LFMD for alerts when major investors trade the stock.

LifeMD is classified in the Healthcare sector. On target price, it currently shows $7. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LFMD with unrelated industries.